Myelodysplastic Syndrome

Showing NaN - NaN of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in New York (ON 01910.Na)

Completed
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • ON 01910.Na
  • New York, New York
    Columbia University Medical Center
Jun 22, 2017

Myelodysplastic Syndrome, MDS, Trisomy 8 Trial in United States (rigosertib)

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Jun 22, 2017

Myelodysplastic Syndrome Trial in New York (ON 01910.Na Concentrate)

Withdrawn
  • Myelodysplastic Syndrome
  • ON 01910.Na Concentrate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 22, 2017

Myelodysplastic Syndrome Trial in Tampa, New York (ON 01910.Na)

Completed
  • Myelodysplastic Syndrome
  • ON 01910.Na
  • Tampa, Florida
  • +1 more
Jun 22, 2017

Allogeneic Stem Cell Transplant, Leukemia, Non-Hodgkins Trial in New York (cytoreductive regimen followed by a CD34+E- selected

Completed
  • Allogeneic Stem Cell Transplant
  • +5 more
  • cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 20, 2017

Myelodysplastic Syndrome Trial in New York (Arsenic Trioxide (Tricenox), Cytarabine)

Completed
  • Myelodysplastic Syndrome
  • New York, New York
    Weill Medcial College of Cornell University
Mar 2, 2017

Myelodysplastic Syndrome Trial in New York (Maitake)

Completed
  • Myelodysplastic Syndrome
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 11, 2016

Cancer, Leukemia, Myelodysplastic Syndrome Trial in New York (Fludarabine, Cyclophosphamide, Transplantation)

Completed
  • Cancer
  • +3 more
  • Fludarabine, Cyclophosphamide
  • Transplantation
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 14, 2016

Hodgkin's Disease, Leukemia, Myelodysplastic Syndrome Trial in New York (Rituximab)

Completed
  • Hodgkin's Disease
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 29, 2015

Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma Trial in New York (BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF)

Completed
  • Leukemia
  • +3 more
  • BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 22, 2015

Structural Imaging and Cognitive Functions in Adult Stem Cell

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • MRI and cognitive evaluation
  • brain MRI study and a brief neuropsychological evaluation
  • New York, New York
  • +1 more
Dec 9, 2015

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)

Completed
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +7 more
Jun 4, 2015

Leukemia, Myelodysplastic Syndrome Trial in New York (ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195)

Completed
  • Leukemia
  • Myelodysplastic Syndrome
  • ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 24, 2015

Myelodysplastic Syndrome Trial in Worldwide (Siltuximab, Placebo, Best supportive care (BSC))

Terminated
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +22 more
Sep 24, 2014

Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • VCL-CB01
  • Phosphate-buffered Saline (PBS)
  • Tucson, Arizona
  • +21 more
Jul 31, 2013

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (Mylotarg, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • New York, New York
    Weill Medcial College of Cornell University
Jun 17, 2013

Myelodysplastic Syndrome Trial in United States (Ezatiostat Hydrochloride, Lenalidomide (Revlimid®))

Completed
  • Myelodysplastic Syndrome
  • Ezatiostat Hydrochloride
  • Lenalidomide (Revlimid®)
  • Phoenix, Arizona
  • +8 more
Jun 4, 2013

Myelodysplastic Syndrome Trial in United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Myelodysplastic Syndrome
  • decitabine (5-aza-2'deoxycytidine)
  • Berkeley, California
  • +23 more
Jan 22, 2013

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (CT53518)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Los Angeles, California
  • +4 more
Mar 23, 2009